Adoption of Hospital Policies for Prevention of Perinatal Group B Streptococcal211 Disease, United States, 1997. Morbidity and Mortality Weekly Report, Vol. 47, No. 211 32, August 21, 1998

摘要

Group B streptococcal (GBS) infections are the leading bacterial cause of disease211u001eand deaths among newborns in the United States. In 1993, the annual cost of 211u001ecaring for newborns with sepsis caused by group B Streptococcus was an estimated 211u001e$294 million. A survey of hospital GBS disease prevention practices in 1994 211u001eindicated that those hospitals with a prenatal screening policy had fewer 211u001eneonatal GBS disease cases. In 1996, to promote a coordinated approach to 211u001eprevention, CDC issued consensus guidelines about GBS disease prevention that 211u001ewere endorsed by the American College of Obstetricians and Gynecologists and the 211u001eAmerican Academy of Pediatrics. These consensus guidelines recommend using either 211u001ea screening-based strategy or a risk-based strategy for identifying women who 211u001eshould receive intrapartum antimicrobial prophylaxis.